Medicine recalls
|
| |
| The United States: Blissful Remedies issues voluntary nationwide recall of certain kratom powder capsule |
| |
The US Food and Drug Administration (FDA) announces that Blissful Remedies., is voluntarily recalling only Lot No.: 112710 with expiration 03/2019 found embedded on the top of package of kratom (mitragyna speciosa) powder products, it manufactured, processed, packed, and/or held, between “March 1, 2018” to “April 30, 2018” to the consumer level. The products have been found by the FDA via sample testing to have Salmonella contamination. Blissful Remedies has not received reports of adverse events related to this recall. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordance to FDA guidelines.
The products are packaged in white foil pouches with Lot No.: 112710 and expiration 03/2019 . The affected products are:
- Red Maeng Da (100% Mitragyna Speciosa) 50 capsules
- Gold Series Ultra Enhanced Indo (100% Mitragyna Speciosa) 50 capsules
- Kratom+CBD., CBD infused Maeng Da 50 capsules
These products have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm612376.htm
In Hong Kong, the above products are not registered pharmaceutical products. There is also no registered pharmaceutical product containing kratom.
Ends/Tuesday, Jul 3, 2018
Issued at HKT 14:00
|
| |
|
